Cas:1121583-63-8 4-Phenoxy-1-benzothiophene-7-carbaldehyde manufacturer & supplier

Chemical Name:4-Phenoxy-1-benzothiophene-7-carbaldehyde

CAS.NO:1121583-63-8

Synonyms:4-phenoxybenzo[b]thiophene-7-carbaldehyde;Benzo[b]thiophene-7-carboxaldehyde, 4-phenoxy-;4-Phenoxy-1-benzothiophene-7-carbaldehyde;I09-1683;4-phenoxy benzo[b]thiophene-7-carbaldehyde

Molecular Formula:C₁₅H₁₀O₂S

Molecular Weight:254.304

HS Code:2934999090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:420.8±30.0 °C at 760 mmHg

Density:1.3±0.1 g/cm3

Index of Refraction:1.702

PSA:54.54000

Exact Mass:254.040146

LogP:6.00

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 4-phenoxybenzo[b]thiophene-7-carbaldehyde chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-phenoxy benzo[b]thiophene-7-carbaldehyde physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-Phenoxy-1-benzothiophene-7-carbaldehyde Use and application,4-Phenoxy-1-benzothiophene-7-carbaldehyde technical grade,usp/ep/jp grade.

Related News: Analysts at Mizuho Americas, who spoke to Lilly’s management this week, said that may well have now changed. “Overall, it sounds like the approval raises new questions for Lilly (as it does for many of us!),” the firm said in a note to clients. 4-Phenoxy-1-benzothiophene-7-carbaldehyde manufacturer Fate Therapeutics has exclusively licensed from MSK foundational intellectual property covering the production and composition of iPSC-derived T cells. 4-Phenoxy-1-benzothiophene-7-carbaldehyde supplier Analysts at Mizuho Americas, who spoke to Lilly’s management this week, said that may well have now changed. “Overall, it sounds like the approval raises new questions for Lilly (as it does for many of us!),” the firm said in a note to clients. 4-Phenoxy-1-benzothiophene-7-carbaldehyde vendor At ASH, scientists from the Company and MSK presented new in vivo preclinical data demonstrating that FT819 exhibits durable tumor control and extended survival. 4-Phenoxy-1-benzothiophene-7-carbaldehyde factory Analysts at Mizuho Americas, who spoke to Lilly’s management this week, said that may well have now changed. “Overall, it sounds like the approval raises new questions for Lilly (as it does for many of us!),” the firm said in a note to clients.